Company

Becton, Dickinson and Company

Headquarters: Franklin Lakes, NJ, United States

Founded: East Rutherford, New Jersey 1897

Employees: 75,000

CEO: Mr. Thomas E. Polen Jr.

show_chart NYSE: BDX +0.62%

Market Cap

$76.98 Billion

USD as of April 1, 2022

history Market Cap History

Company Description

Becton, Dickinson and Company, more simply known as BD, is a medical technology company. It manufactures and markets medical devices, instrument systems, reagents, and provides consulting and analytics services. Founded in 1897, BD was a pioneer of syringes that expanded to other medical supplies such as needles, catheters, and developed a range of medical, diagnostic and research devices.

Becton, Dickinson and Company market capitalization over time

Evolution of Becton, Dickinson and Company market cap in the past 5 years

Market capitalizations are calculated from the opening stock price at the beginning of each month.

history Market Cap History of Becton, Dickinson and Company

Detailed Description

Becton, Dickinson and Company develops, manufactures, and sells medical supplies, devices, laboratory equipment, and diagnostic products for healthcare institutions, physicians, life science researchers, clinical laboratories, pharmaceutical industry, and the general public worldwide. The company's BD Medical segment offers peripheral intravenous (IV) and advanced peripheral catheters, central lines, acute dialysis catheters, vascular care and preparation products, needle-free IV connectors and extensions sets, closed-system drug transfer devices, hazardous drug detections, hypodermic syringes and needles, anesthesia needles and trays, enteral syringes, and sharps disposal systems; IV medication and infusion therapy delivery systems, medication compounding workflow systems, automated medication dispensing and supply management systems, and medication inventory optimization and tracking systems; syringes, pen needles, and other products for diabetes; and prefillable drug delivery systems. Its BD Life Sciences segment provides specimen and blood collection products; automated blood and tuberculosis culturing, molecular testing, microorganism identification and drug susceptibility, and liquid-based cytology systems, as well as rapid diagnostic assays, microbiology laboratory automation products, and plated media products; and fluorescence-activated cell sorters and analyzers, antibodies and kits, reagent systems, and solutions for single-cell gene expression analysis, as well as clinical oncology, immunological, and transplantation diagnostic/monitoring reagents and analyzers. The company's BD Interventional segment offers hernia and soft tissue repair, biological and bioresorbable grafts, biosurgery, and other surgical products; surgical infection prevention, surgical and laparoscopic instrumentation products; peripheral intervention products; and urology and critical care products. The company was founded in 1897 and is based in Franklin Lakes, New Jersey.

Wikipedia Introduction

Coordinates: 41°00′57″N 74°12′36″W / 41.015834°N 74.210136°W / 41.015834; -74.210136 Becton, Dickinson and Company, also known as BD, is an American multinational medical technology company that manufactures and sells medical devices, instrument systems, and reagents. BD also provides consulting and analytics services in certain geographies. BD is ranked #177 in the 2021 Fortune 500 list. In October 2014, the company agreed to acquire CareFusion for a price of US$12.2 billion in cash and stock.

Source: Wikipedia, retrieved on March 31, 2022, 8:55 p.m.

Stocks & Indices

Becton, Dickinson and Company has the following listings and related stock indices.


Stock: NYSE: BDX

Stock: BMV: BDX

Stock: Bovespa: B1DX34

Stock: NYSE: BDXB

Stock: XETR: BOX

Key People

Founder(s): Maxwell Becton and Fairleigh S. Dickinson

Tom Polen (Chairman, CEO and President) Christopher R. Reidy (Executive Vice President and CAO) Christopher Del Orefice (Executive Vice President and CFO)

Financials

Revenue: US$20.248 Billion (Fiscal Year Ended September 30, 2021)

Operating income: US$2.799 Billion (Fiscal Year Ended September 30, 2021)

Net income: US$2.002 Billion (Fiscal Year Ended September 30, 2021)


Total assets: US$53.866 Billion (Fiscal Year Ended September 30, 2021)

Total equity: US$23.677 Billion (Fiscal Year Ended September 30, 2021)

Details

Headquarters:

1 Becton Drive

Franklin Lakes, NJ 07417-1880

United States

Phone: 201 847 6800